Inventor
SCHER DAVID S
US30 patents
⚠️ This page may combine multiple inventors who share the name “SCHER DAVID S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WARSAW ORTHOPEDIC INC
26 patentsUS10736993B2Aug 11, 2020
Implants having a drug load of an oxysterol and methods of use
WARSAW ORTHOPEDIC INC5 citations84
US10632230B2Apr 28, 2020
Implants having a high drug load of an oxysterol and methods of use
WARSAW ORTHOPEDIC INC5 citations84
US10201635B2Feb 12, 2019
Implants having a drug load of an oxysterol and methods of use
WARSAW ORTHOPEDIC INC8 citations84
US9878070B2Jan 30, 2018
Malleable implants including an oxysterol and methods of use
WARSAW ORTHOPEDIC INC13 citations84
US9877836B2Jan 30, 2018
Compression resistant implants including an oxysterol and methods of use
WARSAW ORTHOPEDIC INC10 citations84
US11219702B2Jan 11, 2022
Implants having a drug load of an oxysterol and methods of use
WARSAW ORTHOPEDIC INC2 citations73
US10898498B2Jan 26, 2021
Slow release oxysterols and methods of use
WARSAW ORTHOPEDIC INC1 citations73
US10729702B2Aug 4, 2020
Slow release oxysterols and methods of use
WARSAW ORTHOPEDIC INC1 citations73
US10695182B2Jun 30, 2020
Compression resistant implants including an oxysterol and methods of use
WARSAW ORTHOPEDIC INC3 citations73
US10688222B2Jun 23, 2020
Lyophilized moldable implants containing an oxysterol
WARSAW ORTHOPEDIC INC2 citations73
US10335419B2Jul 2, 2019
Slow release oxysterols and methods of use
WARSAW ORTHOPEDIC INC1 citations73
US9987289B2Jun 5, 2018
Slow release oxysterols and methods of use
WARSAW ORTHOPEDIC INC3 citations73
US9359417B2Jun 7, 2016
Cell cultures and methods of human recombinant growth and differentiaton factor-5 (rhGDF-5)
WARSAW ORTHOPEDIC INC3 citations73
US9266824B2Feb 23, 2016
Methods and compositions for making an amino acid triisocyanate
WARSAW ORTHOPEDIC INC3 citations73
US9051389B2Jun 9, 2015
Expression conditions and methods of human recombinant growth and differentiation factor-5 (rhGDF-5)
WARSAW ORTHOPEDIC INC5 citations73
US8956829B2Feb 17, 2015
Human recombinant growth and differentiaton factor-5 (rhGDF-5)
WARSAW ORTHOPEDIC INC5 citations73
US9914758B2Mar 13, 2018
Methods and compositions comprising human recombinant growth and differentiation factor-5 (rhGDF-5)
WARSAW ORTHOPEDIC INC1 citations63
US9169308B2Oct 27, 2015
Methods and compositions of human recombinant growth and differentiation factor-5 (rhGDF-5) isolated from inclusion bodies
WARSAW ORTHOPEDIC INC3 citations63
US8945872B2Feb 3, 2015
Methods of purifying human recombinant growth and differentiation factor-5 (rhGDF-5) protein
WARSAW ORTHOPEDIC INC3 citations63
US12171665B2Dec 24, 2024
Compression resistant implants including an oxysterol and methods of use
WARSAW ORTHOPEDIC INC0 citations62
US12171909B2Dec 24, 2024
Implants having a drug load of an oxysterol and methods of use
WARSAW ORTHOPEDIC INC0 citations62
US11464888B2Oct 11, 2022
Moldable formulations containing an oxysterol in an acellular tissue matrix
WARSAW ORTHOPEDIC INC0 citations62
US11065123B2Jul 20, 2021
Compression resistant implants including an oxysterol and methods of use
WARSAW ORTHOPEDIC INC0 citations62
US10987450B2Apr 27, 2021
Lyophilized moldable implants containing an oxysterol
WARSAW ORTHOPEDIC INC0 citations62
US9631003B2Apr 25, 2017
Host cell lines expressing human recombinant growth and differentiation factor-5 (rhGDF-5)
WARSAW ORTHOPEDIC INC1 citations52
US9573889B2Feb 21, 2017
Methods and compositions for making an amino acid triisocyanate
WARSAW ORTHOPEDIC INC1 citations52
ALKERMES INC
3 patentsUS6465425B1Oct 15, 2002
Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
ALKERMES INC98 citations97
US6565888B1May 20, 2003
Methods and compositions for the targeted delivery of biologically active agents
ALKERMES INC57 citations96
US7097857B2Aug 29, 2006
Methods and compositions for the targeted delivery of biologically active agents
ALKERMES INC29 citations92